Form 4 for BRVE Braveheart Bio, Inc.
Accepted 2026-08-07 16:41:40 ET · period of report 2026-08-05 · accession 0001470831-26-000804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 16:41 | 2026-08-07 | BRVE | Rickey James Paul | CFO | P - Purchase | $18.00 | +27.8K | 520.9K | +6% | +$500.0K |
| D | 2026-08-07 16:41 | 2026-08-05 | BRVE | Rickey James Paul | CFO | A - Grant | $0.00 | +300.0K | 300.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-07 | P | A | 27,777 | $18.00 | 520,927 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-08-05 | A | A | 300,000 | $0.00 | 300,000 | D | $18.00 · — to 2036-08-04 | 300,000 Common Stock | (F2) 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of July 23, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. |